Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
Sponsor: Vega Therapeutics, Inc
Summary
The VIVID study is structured in a master protocol format comprised of multiple parts that evaluate intravenous (IV) and subcutaneous (SC) VGA039 in healthy volunteers and subjects with von Willebrand Disease (VWD) and other bleeding disorders.
Official title: A Multi-Modular Trial to Evaluate VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease and Other Bleeding Disorders (VIVID)
Key Details
Gender
All
Age Range
12 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
116
Start Date
2023-03-16
Completion Date
2029-12
Last Updated
2025-08-26
Healthy Volunteers
Yes
Conditions
Interventions
VGA039
Single doses of VGA039
Placebo
Single doses of Placebo
VGA039
Multiple doses of VGA039
Locations (25)
Orthopedic Institute for Children (UCLA)
Los Angeles, California, United States
UC Davis Medical Center
Sacramento, California, United States
University of Colorado School of Medicine
Aurora, Colorado, United States
Hemophilia of Georgia Center for Bleeding & Clotting Disorders of Emory
Atlanta, Georgia, United States
Science 37, Inc.
Morrisville, North Carolina, United States
Hemophilia Center of Western PA
Pittsburgh, Pennsylvania, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
University of Texas Southwestern
Dallas, Texas, United States
Washington Center for Bleeding Disorders
Seattle, Washington, United States
Versiti Comprehensive Center for Bleeding Disorders
Milwaukee, Wisconsin, United States
Royal Brisbane & Women's Hospital, Queensland Haemophilia Centre
Herston, Queenland, Australia
Medical University of Vienna
Vienna, Vienna, Austria
Centro de Hemoterapia e Hematologia do Rio de Janeiro HEMORIO
Rio de Janeiro, Rio de Janeiro, Brazil
Hemocentro Unicamp
Campinas, São Paulo, Brazil
Hospital das Clinicas - USP Endereco
São Paulo, São Paulo, Brazil
Hamilton Health Sciences Corporation
Hamilton, Ontario, Canada
Queens University
Kingston, Ontario, Canada
St. Michaels Hospital
Toronto, Ontario, Canada
K J Somaiya Super Speciality Hospital & Research Centre
Sion, Mumbai, India
Charlotte Maxeke Johannesburg Academic Hospital
Johannesburg, South Africa
Queen Elizabeth Hospital Birmingham
Birmingham, Edgbaston, United Kingdom
University Hospital Southampton NHS Foundation Trust
Southampton, Hampshire, United Kingdom
Royal Free Hospital
London, London, United Kingdom
Royal London Hospital, Clinical Haematology Research
Whitechapel, London, United Kingdom
Imperial College Healthcare NHS Trust- Queen Charlotte's & Chelsea Hospital
London, United Kingdom